501 results on '"Schwendeman, Steven P."'
Search Results
2. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release
3. Mechanistic analysis of the photolytic decomposition of solid-state S-nitroso-N-acetylpenicillamine
4. Aqueous remote loading of setmelanotide in poly(lactic-co-glycolic acid) microspheres for long-term obesity treatment
5. In vitro degradation and erosion behavior of commercial PLGAs used for controlled drug delivery
6. Mechanistic evaluation of the initial burst release of leuprolide from spray-dried PLGA microspheres
7. In vitro performance of composition-equivalent PLGA microspheres encapsulating exenatide acetate by solvent evaporation
8. Influence of encapsulation variables on formation of leuprolide-loaded PLGA microspheres
9. Mapping in vivo microclimate pH distribution in exenatide-encapsulated PLGA microspheres
10. Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation method
11. Optimizing zinc-HisTag coordination remote loading of proteins in PLGA microspheres
12. Core-shell microneedle patch for six-month controlled-release contraceptive delivery
13. Clinical translation of long-acting drug delivery formulations
14. Coaxial electrospray of uniform polylactide core-shell microparticles for long-acting contraceptive
15. Characterization of commercial PLGAs by NMR spectroscopy
16. Development and characterization of composition-equivalent formulations to the Sandostatin LAR® by the solvent evaporation method
17. Efficient aqueous remote loading of peptides in poly(lactic-co-glycolic acid)
18. Immediate detachment of microneedles by interfacial fracture for sustained delivery of a contraceptive hormone in the skin
19. Microencapsulation of luteinizing hormone-releasing hormone agonist in poly (lactic-co-glycolic acid) microspheres by spray-drying
20. Feedback-controlled photolytic gas phase nitric oxide delivery from S-nitrosothiol-doped silicone rubber films
21. Predicting drug release kinetics from nanocarriers inside dialysis bags
22. Stability of Proteins and Their Delivery from Biodegradable Polymer Microspheres
23. Infliximab Biosimilars in the Age of Personalized Medicine
24. Rapidly separable microneedle patch for the sustained release of a contraceptive
25. Correction to: Characterization of commercial PLGAs by NMR spectroscopy
26. Mechanisms of in vivo release of triamcinolone acetonide from PLGA microspheres
27. Data from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
28. Supplemental Table S1 from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions
29. Supplemental Figure S1 from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions
30. Supplemental Figure 2 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
31. Data from Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions
32. Supplemental Figure 4 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
33. Supplemental Figure 5 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
34. Supplemental Figure Legends from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
35. Supplemental Figure 1 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
36. Supplemental Figure 2 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
37. Supplemental Figure 5 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
38. Supplemental Figure 3 from Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype
39. Supplemental Figure 3 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
40. Data from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
41. Supplemental Figure 1 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
42. Supplemental Table 1 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
43. Supplemental Figure 4 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
44. Supplemental Table 2 from Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention
45. Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation
46. Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres
47. Biodegradable poly(lactic-co-glycolic acid) microspheres loaded with S-nitroso-N-acetyl-D-penicillamine for controlled nitric oxide delivery
48. Injectable PLGA Systems for Delivery of Vaccine Antigens
49. A biomimetic approach to active self-microencapsulation of proteins in PLGA
50. Injectable controlled release depots for large molecules
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.